Bioneer Corporation

Bioneer Corporation specializes in in vitro diagnostic (IVD) devices focused on nucleic acid processing. Their primary offerings include nucleic acid extraction and isolation kits—such as viral DNA/RNA, genomic DNA, and mycobacterial genomic DNA kits—alongside automated sample preparation instruments and thermal cyclers for laboratory use. These devices support critical steps in molecular diagnostics, including sample preparation and amplification analysis.

Bioneer Corporation is headquartered in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations, including classification under FDA’s risk-based categories (Class I or Class II) and potential requirements for premarket submission or registration, depending on the device’s intended use and risk level. The U.S. regulatory framework ensures these devices meet safety, performance, and labeling standards before commercialization.

Bioneer Corporation’s devices are included in the FDA’s Unique Device Identifier (UDI) database. The UDI system provides a standardized, globally recognized identifier for medical devices, enabling transparency in tracking, compliance, and post-market surveillance. This listing helps healthcare providers, regulators, and other stakeholders verify device details and compliance status.

Bioneer Corporation’s devices fall into FDA’s Class I or Class II categories. Classification is determined by the device’s risk level: Class I generally includes low-risk items requiring general controls (e.g., labeling, manufacturing practices), while Class II devices involve higher risks and may require additional performance standards or post-market surveillance. The specific classification depends on factors like the device’s intended use, potential harm, and the body system it interacts with.

Listing in the FDA’s UDI database means the device has been assigned a unique identifier (UDI) that includes a device identifier and a production identifier. This system ensures traceability throughout the device’s lifecycle, from manufacturing to patient use, and supports regulatory compliance, recall management, and post-market monitoring. It also aids healthcare providers in verifying device authenticity and compliance with FDA requirements.